POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. BSEM, a number one MedTech firm centered on the event, manufacturing, and commercialization of placental-derived merchandise for superior wound care, is happy to announce that its Chief Govt Officer, Jason Matuszewski, can be presenting and holding one-on-one conferences on the upcoming Centri Capital Conference on April 22, 2025, going down on the Nasdaq headquarters in New York Metropolis.
BioStem Applied sciences Presentation Entry:
- Presenter: Jason Matuszewski, Chief Govt Officer
- Date: Tuesday, April 22, 2025
- Time: 10:30 AM ET
- Webcast Hyperlink & Archive: HERE
- 1-on-1 Assembly Request: [email protected]
Be a part of BioStem’s Distribution Record & Social Media:
To observe the newest developments at BioStem, sign-up to the Firm’s electronic mail distribution record HERE, and observe us on Twitter and LinkedIn.
About BioStem Applied sciences, Inc. BSEM:
BioStem Applied sciences is a number one innovator centered on harnessing the pure properties of perinatal tissue within the growth, manufacture, and commercialization of allografts. The Firm is targeted on manufacturing merchandise that change lives, leveraging its proprietary BioREtain® processing technique. BioREtain® has been developed by making use of the newest analysis in superior wound care, centered on sustaining development components and preserving tissue construction. BioStem Applied sciences’ high quality administration system and customary working procedures have been reviewed and accredited by the American Affiliation of Tissue Banks (“AATB”). These methods and procedures are established per present Good Tissue Practices (“cGTP”) and present Good Manufacturing Processes (“cGMP”). Our portfolio of high quality manufacturers consists of AmnioWrap2™, VENDAJE®, VENDAJE AC®, and VENDAJE OPTIC®. Every BioStem Applied sciences placental allograft is processed on the Firm’s FDA registered and AATB accredited web site in Pompano Seashore, Florida.
For extra info go to biostemtechnologies.com and observe us on Twitter and LinkedIn.
BioStem Applied sciences, Inc.
Cellphone: 954-380-8342
Web site: http://www.biostemtechnologies.com
E-Mail: [email protected]
Twitter: @BSEM_Tech
Fb: BioStem Technologies
Investor Relations
Adam Holdsworth
[email protected]
917-497-9287
Market Information and Knowledge dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
